image
Healthcare - Biotechnology - NASDAQ - US
$ 18.09
-0.768 %
$ 95.5 M
Market Cap
-9.62
P/E
BALANCE SHEET
7.35 M ASSETS
-44.47%
1.76 M LIABILITIES
-43.98%
5.59 M EQUITY
-44.62%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Monopar Therapeutics Inc.
image
Current Assets 7.33 M
Cash & Short-Term Investments 7.27 M
Receivables 0
Other Current Assets 66.4 K
Non-Current Assets 12.6 K
Long-Term Investments 0
PP&E 12.6 K
Other Non-Current Assets 0
Current Liabilities 1.76 M
Accounts Payable 1.76 M
Short-Term Debt 0
Other Current Liabilities 0
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 7.3 8.2 20.3 16.7 13.2 6.9 9.0 2.1 2.0
Short Term Investments 0 4.9 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 66.4 K 46 K 0.2 62.7 K 15.7 K 0.4 0.1 22.6 K 22.9 K
Total Current Assets 7.3 13.2 20.5 16.8 13.2 7.3 9.1 2.1 2.0
PP&E 12.6 K 61.2 K 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0.8 0.8 0.8
Other Long Term Assets 0 0 0 68.9 K 0.1 0.4 0 0 0
Other Assets 0 0 0 0 0 (0.4) 0 0 0
Total Assets 7.3 13.2 20.5 16.9 13.4 7.3 9.9 2.9 2.8
LIABILITIES
Accounts Payable 1.8 3.1 1.6 1.2 0.7 0.4 0.3 64.5 K 73.8 K
Short Term Debt 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0 0 0 0 0
Total Current Liabilities 1.8 3.1 1.6 1.2 0.7 0.4 0.3 64.5 K 73.8 K
Long Term Debt 0 8.41 K 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0
Total Liabilities 1.8 3.1 1.6 1.2 0.7 0.4 0.3 64.5 K 73.8 K
EQUITY
Common Stock 14.9 K 12.9 K 12.6 K 11.5 K 10.6 K 9.29 K 9.29 K 0 0
Retained Earnings (60.2) (51.8) (41.3) (32.2) (25.9) (21.7) (18.4) (1.9) (0.7)
Other Accumulative Comprehensive Income/Loss 14.1 K 8.94 K 3.16 K 7.87 K 11 K 2.4 K 0 0 0
Total Equity 5.6 10.1 18.9 15.7 12.6 6.9 9.6 2.8 2.8
Total Liabilities and Equity 7.3 13.2 20.5 16.9 13.4 7.3 9.9 2.9 2.8
SHARES OUTSTANDING
Common Shares Outstanding 14.5 12.7 12.5 11.0 10.6 10.4 10.4 10.4 10.6